GlassScriptPhysician profile
Jordan B Simcox
NPI 1760509376
$2,076.71
in general payments reported to CMS, 2019-2025
15 companies · $629 in 2025
The $629 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $38.40 · 2022: $579 · 2023: $391 · 2024: $439 · 2025: $629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,459.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $454.86 | 2021-2025 | Rexulti |
| Lundbeck LLC | $310.69 | 2022-2025 | Rexulti, Brintellix |
| Abbvie INC. | $258.02 | 2022-2025 | |
| Corium, LLC | $201.23 | 2023-2025 | Azstarys |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $179.12 | 2023-2025 | Caplyta |
| Supernus Pharmaceuticals, INC. | $174.66 | 2023-2025 | Qelbree, Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $133.66 | 2022-2023 | Trintellix |
| Vanda Pharmaceuticals INC. | $91.56 | 2025 | Fanapt |
| Collegium Pharmaceutical, INC. | $51.86 | 2025 | Jornay Pm |
| Vertical Pharmaceuticals, LLC | $47.87 | 2024-2025 | Relexxii |
| Teva Pharmaceuticals USA, INC. | $39.89 | 2022 | |
| Axsome Therapeutics, INC. | $35.99 | 2025 | Auvelity |
| Neos Therapeutics, LP | $34.84 | 2024-2025 | Adzenys Xr-Odt |
| Janssen Pharmaceuticals, INC | $33.57 | 2023-2025 | Spravato |
| Alkermes, INC. | $28.89 | 2025 | Aristada, Lybalvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Simcox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.